With the new ‘Enterprise’ product, large companies can opt for an on-premises deployment…
“It is great to be leading the world in software development for AI…”
Some of the world’s most influential governments in medical regulation have released guidelines for machine learning practices used in the development of medical Artificial Intelligence (AI).
In Autumn 2021, gliff.ai completed a feasibility study for an anti-counterfeiting imaging artificial intelligence (AI) platform, working in partnership with Durham University and a multinational manufacturer.
The aim of the OCT data project is to create a ground-truth annotated dataset that would be utilised for the future development of fully automated AI tool capable of segmenting and quantifying different features in retina images and scans…
gliff.ai has launched its innovative software platform, specifically designed to assist the development of trustworthy Artificial Intelligence (AI) by addressing the gap for much-needed Machine Learning Operations (MLOps) products.
MLOps brings together scientists who develop these early stage AI systems with engineers and operations experts who are able to convert these AI models into reliable and scalable products such as apps on your phone or smart microscopes in the hospital.